News Overview

Biopôle to Gain a New Building Dedicated to Life Sciences

Author: Switzerland Innovation Park Network West EPFL - Biopôle Lausanne

The canton of Vaud’s pension fund will finance and construct the new building on the Biopôle site of the Switzerland Innovation Park Network West EPFL near Lausanne.

The new building will meet the growing demand for space for laboratories, offices and services. Construction is due to be completed in the first quarter of 2023. The new 9,900 m² structure will be home to offices and laboratories for life sciences companies, and it will have a rooftop kiosk for service providers. The project also includes a central car park with 278 spaces to cater for the northern part of the site. Around 150 people will work in the building, adding to the 1,700 people working at the Biopôle site today.

‘Barely a year and a half after our latest building opened, this new project demonstrates the energy and attractiveness of our ecosystem and will contribute to the increasing competitiveness of our region in the field of life sciences. It strengthens the infrastructure, skills and networks that we provide to a unique community. We are delighted that the canton of Vaud’s pension fund has confidence in our value proposition, and we look forward to a dynamic and fruitful collaboration with them,’ said Nasri Nahas, CEO of Biopôle SA.

Created in 2004 by the canton of Vaud, Biopôle is a science park that links companies and universities active in the field of life sciences. The site offers high-quality infrastructure and value-added services as well as exceptional living spaces and community engagement – all to enable our members to thrive and bring science to life. The site is home to more than a hundred companies and organizations, including the head offices of multinationals, start-ups, SMEs, clinical development teams and technology and service providers. It also hosts more than 25 world-renowned research groups, notably from the Vaud University Hospital Center (CHUV), the University of Lausanne (UNIL) and the Ludwig Institute for Cancer Research, with which our companies actively collaborate.